0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Advanced Wound Care Market: Global Opportunity Analysis and Industry Forecast, 2020–2027
Published Date: November 2019
|
Report Code: ALLI-Auto-1V75
Home | Category |Health |Health Conditions
Advanced Wound Care Market by Product Type Infection Management Exudate Management Active Wound Care Therapy Devices Application Chronic Wounds and Acute Wounds End User Hospitals and Community Centers Global Opportunity Analysis and Industry Forecast 2014 2022

Advanced Wound Care Market: Global Opportunity Analysis and Industry Forecast, 2020–2027

Code: ALLI-Auto-1V75
Report
November 2019
261 Pages
Allied Market Research
Region: Global,
Description
Table of Content
Tables & Figures

ADVANCED WOUND CARE MARKET - 2027

The advanced wound care market size was valued at $9,255.70 million in 2019, and is estimated to reach at $15,305.94 million by 2027, registering a CAGR of 11.6% from 2020 to 2027.

Advanced wound care (AWC) products are designed to treat acute & chronic wounds. Chronic wounds take more time to heal and are expensive to treat. Advanced wound care is developing as a standard solution for treating chronic wounds. Traditional wound care products are being increasingly replaced with advanced wound care products, owing to their efficiency & effectiveness in managing wounds by enabling faster healing. Moreover, they help to maintain a hydrated environment, keep temperature consistent, allow flow of oxygen, protect the injured site from exogenous infection, and ease pain associated with dressing changes. Advanced wound care products include hydrocolloids, hydrogels, film & foam dressings, alginates, and others.

Advanced Wound Care - Global Market Study and Forecast Report 2025

Significant increase in the prevalence of chronic diseases such as diabetes and obesity, rise in geriatric population, technological advancements, problems associated with traditional wound healing methods, and surge in adoption of evidence-based treatments for chronic wounds fuel the growth of the advanced wound care market. Moreover, rise in awareness programs for advanced wound care treatment & management attempts to reduce the duration of the hospital stay to lower healthcare expenses, and rise in inclination toward wound care products that enhance therapeutic outcomes are other factors that contribute toward the growth of the market. However, the high costs of advanced wound care products are expected to hinder the growth of the market.

 

ADVANCED WOUND CARE MARKET SEGMENTATION

The advanced wound care market is segmented on the basis of product, application, end-user, and region. By product, the market is segmented into infection management, exudate management, active wound care, and therapy devices. Infection management is further sub-segmented into silver dressings, non-silver dressings, and collagens. The exudate management is further sub-segmented into hydrocolloid dressings, foam dressings, alginate dressings, and hydrogel dressings. The active wound care is further sub-segmented into skin substitutes and growth factors. The therapy devices are further sub-segmented into negative pressure wound therapy (NPWT), oxygen and hyperbaric oxygen equipment, electromagnetic therapy devices, and others. Based on the application, the market is bifurcated into chronic wounds and acute wounds. The chronic wounds is further sub-segmented into pressure ulcers, diabetic foot ulcers, venous leg ulcers, and arterial ulcers. The acute wounds is further sub-segmented into burns & trauma, and surgical wounds. Based on end-user, the advanced wound care market is classified into hospitals and community health service centers. On the basis of region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Advanced Wound Care Market - Global Market Research Report and Future Forecast 2025

Product segment review

Based on advanced wound care market analysis, by product, the market is segmented into infection management, exudate management, active wound care, and therapy devices. The therapy devices segment acquired the largest advanced wound care market share in 2018. Furthermore, this segment is also expected to experience a growth at the fastest rate during the forecast period owing to an increase in the incidence rate of chronic diseases such as diabetes & obesity and a rise in demand for innovative & advanced wound care products

Application Segment review

According to the application, the chronic wound segment generated the highest revenue in 2018 and is expected to maintain its dominance throughout the forecast period. This is attributed to surge in prevalence of post-operative surgical wounds, rise in geriatric population, increase in awareness and improved diagnosis, and technological advancements, which has driven the demand for use of advanced wound care products worldwide.

North America occupied the largest share of the advanced wound care market in 2018 and is expected to maintain its dominance during the forecast period owing to large availability of trained medical professionals, availability of well-developed infrastructure facilities, and presence of majority of key players. However, Asia-Pacific is expected to witness the highest growth rate throughout the forecast period, due to its high population base, surge in disposable income, and rise in patient awareness toward advanced wound care treatment & management. In addition, increase in the geriatric population is the key contributor for the market growth in the region.

The major companies profiled in this report include 3M (Acelity Inc.), Adynxx, Inc., B Braun Melsungen AG, Coloplast A/S, ConvaTec Group plc, Essity AB (BSN Medical GmbH), Integra Lifesciences (Derma sciences), Investor AB (Mölnlycke Health Care AB), Johnson & Johnson, Medline Industries, Inc., Medtronic plc., Organogenesis Holdings Inc., and Smith & Nephew Plc.

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate imminent investment pockets.
  • It offers a quantitative analysis from 2019 to 2027, which is expected to enable stakeholders to capitalize on prevailing advanced wound care market opportunities.
  • The key market players and their strategies have been analyzed to understand the competitive outlook of the advanced wound care market.

By Product type

  • Infection Management 
    • Silver Wound Dressings
    • Non-silver Dressings
    • Collagen Dressings
  • Exudate Management 
    • Hydrocolloids Dressings
    • Foam Dressings
    • Alginate Dressings
    • Hydrogel Dressings
  • Active Wound Care 
    • Skin Substitutes
    • Growth Factors
  • Therapy Devices 
    • Negative Pressure Wound Therapy (NPWT)
    • Oxygen and Hyperbaric Oxygen Equipment
    • Electromagnetic Therapy Devices
    • Others

By Application

  • Chronic Wounds
    • Pressure Ulcers
    • Diabetic Foot Ulcers
    • Venous Leg Ulcers
    • Arterial Ulcers
  • Acute Wounds
    • Burns & Trauma
    • Surgical Wounds

By End User

  • Hospitals
  • Community Health Service Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 
 
 

 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five force analysis
3.4.Market share analysis

3.4.1.Drivers

3.4.1.1.Rise in geriatric population
3.4.1.2.Upsurge in incidences of diabetes, obesity, and chronic conditions
3.4.1.3.Technological advancements to deal with complex wounds

3.4.2.Restrains

3.4.2.1.High cost of advanced wound care products

3.4.3.Opportunities

3.4.3.1.Untapped opportunities in developing economies

3.5.Market dynamics
3.6.COVID-19 impact on the market

CHAPTER 4:ADVANCED WOUND CARE MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Infection management

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Market size and forecast, by type
4.2.5.Silver wound dressings

4.2.5.1.Market size and forecast

4.2.6.Non-silver dressings

4.2.6.1.Market size and forecast

4.2.7.Collagen dressings

4.2.7.1.Market size and forecast

4.3.Exudate management

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.3.4.Market size and forecast, by product
4.3.5.Hydrocolloid dressings

4.3.5.1.Market size and forecast

4.3.6.Foam dressings

4.3.6.1.Market size and forecast

4.3.7.Alginate dressings

4.3.7.1.Market size and forecast

4.3.8.Hydrogel dressings

4.3.8.1.Market size and forecast

4.4.Active wound care

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
4.4.4.Market size and forecast, by type
4.4.5.Skin substitutes

4.4.5.1.Market size and forecast

4.4.6.Growth factors

4.4.6.1.Market size and forecast

4.5.Therapy devices

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast
4.5.3.Market analysis, by country
4.5.4.Market size and forecast, by type
4.5.5.Negative pressure wound therapy (NPWT)

4.5.5.1.Market size and forecast

4.5.6.Oxygen & hyperbaric oxygen equipment

4.5.6.1.Market size and forecast

4.5.7.Electromagnetic therapy devices

4.5.7.1.Market size and forecast

4.5.8.Others

4.5.8.1.Market size and forecast

CHAPTER 5:ADVANCED WOUND CARE MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Chronic wounds

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.2.3.Market size and forecast, by type
5.2.4.Pressure ulcers

5.2.4.1.Market size and forecast

5.2.5.Diabetic foot ulcers

5.2.5.1.Market size and forecast

5.2.6.Venous leg ulcers

5.2.6.1.Market size and forecast

5.2.7.Arterial ulcers

5.2.7.1.Market size and forecast

5.3.Acute wounds

5.3.1.Market size and forecast
5.3.2.Market analysis, by country
5.3.3.Market size and forecast, by type
5.3.4.Burns & trauma

5.3.4.1.Market size and forecast

5.3.5.Surgical wounds

5.3.5.1.Market size and forecast

CHAPTER 6:ADVANCED WOUND CARE MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Hospitals

6.2.1.Market size and forecast
6.2.2.Market analysis, by country

6.3.Community health service centers

6.3.1.Market size and forecast
6.3.2.Market analysis, by country

CHAPTER 7:ADVANCED WOUND CARE MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country

7.2.2.1.U.S. advanced wound care market, by product
7.2.2.2.U.S. advanced wound care market, by application
7.2.2.3.U.S. advanced wound care market, by end user
7.2.2.4.Mexico advanced wound care market, by product
7.2.2.5.Mexico advanced wound care market, by application
7.2.2.6.Mexico advanced wound care market, by end user
7.2.2.7.Canada advanced wound care market, by product
7.2.2.8.Canada advanced wound care market, by application
7.2.2.9.Canada advanced wound care market, by end user

7.2.3.North America market size and forecast, by product
7.2.4.North America market size and forecast, by application
7.2.5.North America market size and forecast, by end user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country

7.3.2.1.Germany advanced wound care market, by product
7.3.2.2.Germany advanced wound care market, by application
7.3.2.3.Germany advanced wound care market, by end user
7.3.2.4.UK advanced wound care market, by product
7.3.2.5.UK advanced wound care market, by application
7.3.2.6.UK advanced wound care market, by end user
7.3.2.7.France advanced wound care market, by product
7.3.2.8.France advanced wound care market, by application
7.3.2.9.France advanced wound care market, by end user
7.3.2.10.Italy advanced wound care market, by product
7.3.2.11.Italy advanced wound care market, by application
7.3.2.12.Italy advanced wound care market, by end user
7.3.2.13.Spain advanced wound care market, by product
7.3.2.14.Spain advanced wound care market, by application
7.3.2.15.Spain advanced wound care market, by end user
7.3.2.16.Rest of Europe advanced wound care market, by product
7.3.2.17.Rest of Europe advanced wound care market, by application
7.3.2.18.Rest of Europe advanced wound care market, by end user

7.3.3.Europe market size and forecast, by product
7.3.4.Europe market size and forecast, by application
7.3.5.Europe market size and forecast, by end user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country

7.4.2.1.Japan advanced wound care market, by product
7.4.2.2.Japan advanced wound care market, by application
7.4.2.3.Japan advanced wound care market, by end user
7.4.2.4.China advanced wound care market, by product
7.4.2.5.China advanced wound care market, by application
7.4.2.6.China advanced wound care market, by end user
7.4.2.7.India advanced wound care market, by product
7.4.2.8.India advanced wound care market, by application
7.4.2.9.India advanced wound care market, by end user
7.4.2.10.Rest of Asia-Pacific advanced wound care market, by product
7.4.2.11.Rest of Asia-Pacific advanced wound care market, by application
7.4.2.12.Rest of Asia-Pacific advanced wound care market, by end user

7.4.3.Asia-Pacific market size and forecast, by product
7.4.4.Asia-Pacific market size and forecast, by application
7.4.5.Asia-Pacific market size and forecast, by end user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country

7.5.2.1.Brazil advanced wound care market, by product
7.5.2.2.Brazil advanced wound care market, by application
7.5.2.3.Brazil advanced wound care market, by end user
7.5.2.4.Saudi Arabia advanced wound care market, by product
7.5.2.5.Saudi Arabia advanced wound care market, by application
7.5.2.6.Saudi Arabia advanced wound care market, by end user
7.5.2.7.South Africa advanced wound care market, by product
7.5.2.8.South Africa advanced wound care market, by application
7.5.2.9.South Africa advanced wound care market, by end user
7.5.2.10.Rest of LAMEA advanced wound care market, by product
7.5.2.11.Rest of LAMEA advanced wound care market, by application
7.5.2.12.Rest of LAMEA advanced wound care market, by end user

7.5.3.LAMEA market size and forecast, by product
7.5.4.LAMEA market size and forecast, by application
7.5.5.LAMEA market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

8.1.3M (ACELITY INC.)

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments

8.2.ADYNXX, INC.

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Key strategic moves and developments

8.3.B. BRAUN MELSUNGEN AG

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance

8.4.COLOPLAST A/S

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance

8.5.CONVATEC GROUP PLC.

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance

8.6.ESSITY AB (BSN MEDICAL GMBH)

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments

8.7.INTEGRA LIFESCIENCES HOLDINGS CORPORATION (DERMA SCIENCES)

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments

8.8.INVESTOR AB (MÖLNLYCKE HEALTH CARE AB)

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments

8.9.JOHNSON & JOHNSON

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance

8.10.MEDLINE INDUSTRIES, INC.

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio

8.11.MEDTRONIC PLC.

8.11.1.Company overview
8.11.2.Company snapshot
8.11.3.Operating business segments
8.11.4.Product portfolio
8.11.5.Business performance

8.12.ORGANOGENESIS HOLDINGS INC.

8.12.1.Company overview
8.12.2.Company snapshot
8.12.3.Operating business segments
8.12.4.Product portfolio
8.12.5.Business performance

8.13.SMITH & NEPHEW PLC.

8.13.1.Company overview
8.13.2.Company snapshot
8.13.3.Operating business segments
8.13.4.Product portfolio
8.13.5.Business performance

TABLE 01.GLOBAL INCIDENCES OF DIABETES, 2011 VS. 2030 (IN MILLION)
TABLE 02.GLOBAL ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 03.INFECTION MANAGEMENT ADVANCED WOUND CARE MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 04.INFECTION MANAGEMENT ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 05.EXUDATE MANAGEMENT ADVANCED WOUND CARE MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 06.EXUDATE MANAGEMENT ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 07.ADVANCED WOUND CARE MARKET FOR ACTIVE WOUND CARE, BY REGION, 2019–2027 ($MILLION)
TABLE 08.ACTIVE WOUND CARE MARKET ADVANCED WOUND CARE, BY TYPE, 2019–2027 ($MILLION)
TABLE 09.THERAPY DEVICES ADVANCED WOUND CARE MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 10.THERAPY DEVICES ADVANCED WOUND CARE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 11.GLOBAL ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 12.CHRONIC WOUND CARE MARKET, BY REGION, 2018–2027 ($MILLION)
TABLE 13.CHRONIC WOUND CARE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 14.PRESSURE ULCER-RELATED PRODUCTS AND MANUFACTURERS
TABLE 15.CLINICAL TRIALS 1 – PRESSURE ULCERS
TABLE 16.CLINICAL TRIALS 2 - PRESSURE ULCERS
TABLE 17.CLINICAL TRIALS 1 - DIABETIC FOOT ULCERS
TABLE 18.CLINICAL TRIALS 2 - DIABETIC FOOT ULCERS
TABLE 19.CLINICAL TRIALS 1 – VENOUS LEG ULCERS
TABLE 20.CLINICAL TRIALS 2 - VENOUS LEG ULCERS
TABLE 21.CLINICAL TRIALS – ARTERIAL ULCERS
TABLE 22.ACUTE WOUND CARE MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 23.ACUTE WOUND CARE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 24.GLOBAL ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 25.ADVANCED WOUND CARE MARKET FOR HOSPITALS, BY REGION, 2019–2027 ($MILLION)
TABLE 26.ADVANCED WOUND CARE MARKET FOR COMMUNITY HEALTH SERVICE CENTERS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 27.ADVANCED WOUND CARE MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 28.NORTH AMERICA ADVANCED WOUND CARE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 29.U.S. ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 30.U.S. ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 31.U.S. ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 32.MEXICO ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 33.MEXICO ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 34.MEXICO ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 35.CANADA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 36.CANADA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 37.CANADA ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 38.NORTH AMERICA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 39.NORTH AMERICA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 40.NORTH AMERICA ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 41.EUROPE ADVANCED WOUND CARE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 42.GERMANY ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 43.GERMANY ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 44.GERMANY ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 45.UK ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 46.UK ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 47.UK ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 48.FRANCE ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 49.FRANCE ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 50.FRANCE ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 51.ITALY ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 52.ITALY ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 53.ITALY ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 54.SPAIN ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 55.SPAIN ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 56.SPAIN ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 57.REST OF EUROPE ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 58.REST OF EUROPE ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 59.REST OF EUROPE ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 60.EUROPE ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 61.EUROPE ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 62.EUROPE ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 63.ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 64.JAPAN ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 65.JAPAN ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 66.JAPAN ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 67.CHINA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 68.CHINA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 69.CHINA ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 70.INDIA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 71.INDIA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 72.INDIA ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 73.REST OF ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 74.REST OF ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 75.REST OF ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 76.ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 77.ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 78.ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 79.LAMEA ADVANCED WOUND CARE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 80.BRAZIL ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 81.BRAZIL ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 82.BRAZIL ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 83.SAUDI ARABIA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 84.SAUDI ARABIA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 85.SAUDI ARABIA ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 86.SOUTH AFRICA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 87.SOUTH AFRICA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 88.SOUTH AFRICA ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 89.REST OF LAMEA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 90.REST OF LAMEA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 91.REST OF LAMEA ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 92.LAMEA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 93.LAMEA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 94.LAMEA ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 95.3M: COMPANY SNAPSHOT
TABLE 96.3M: OPERATING SEGMENTS
TABLE 97.3M: PRODUCT PORTFOLIO
TABLE 98.ADYNXX: COMPANY SNAPSHOT
TABLE 99.ADYNXX: PRODUCT PORTFOLIO
TABLE 100.B. BRAUN: COMPANY SNAPSHOT
TABLE 101.B. BRAUN :OPERATING SEGMENTS
TABLE 102.B BRAUN: PRODUCT PORTFOLIO
TABLE 103.COLOPLAST: COMPANY SNAPSHOT
TABLE 104.COLOPLAST: OPERATING SEGMENTS
TABLE 105.COLOPLAST: PRODUCT PORTFOLIO
TABLE 106.CONVATEC: COMPANY SNAPSHOT
TABLE 107.CONVATEC: OPERATING SEGMENTS
TABLE 108.CONVATEC: PRODUCT PORTFOLIO
TABLE 109.ESSITY: COMPANY SNAPSHOT
TABLE 110.ESSITY: OPERATING SEGMENTS
TABLE 111.ESSITY: PRODUCT PORTFOLIO
TABLE 112.INTEGRA LIFESCIENCES: COMPANY SNAPSHOT
TABLE 113.INTEGRA LIFESCIENCES: OPERATING SEGMENTS
TABLE 114.INTEGRA LIFESCIENCES: PRODUCT PORTFOLIO
TABLE 115.INVESTOR: COMPANY SNAPSHOT
TABLE 116.INVESTOR: OPERATING SEGMENTS
TABLE 117.INVESTOR: PRODUCT PORTFOLIO
TABLE 118.J&J: COMPANY SNAPSHOT
TABLE 119.J&J: OPERATING SEGMENTS
TABLE 120.J&J: PRODUCT PORTFOLIO
TABLE 121.MEDLINE: COMPANY SNAPSHOT
TABLE 122.MEDLINE: OPERATING SEGMENTS
TABLE 123.MEDLINE: PRODUCT PORTFOLIO
TABLE 124.MEDTRONIC: COMPANY SNAPSHOT
TABLE 125.MEDTRONIC: OPERATING SEGMENTS
TABLE 126.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 127.ORGANOGENESIS: COMPANY SNAPSHOT
TABLE 128.ORGANOGENESIS: OPERATING SEGMENTS
TABLE 129.ORGANOGENESIS: PRODUCT PORTFOLIO
TABLE 130.SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 131.SMITH & NEPHEW: OPERATING SEGMENTS
TABLE 132.SMITH & NEPHEW: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.GLOBAL ADVANCED WOUND CARE MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017–2020
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2020 (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2017–2020
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTES
FIGURE 09.LOW THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.MARKET SHARE ANALYSIS
FIGURE 12.MARKET DYNAMICS
FIGURE 13.COMPARATIVE ANALYSIS OF INFECTION MANAGEMENT ADVANCED WOUND CARE MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 14.SILVER WOUND DRESSINGS ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 15.NON-SILVER DRESSINGS ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 16.COLLAGEN DRESSINGS ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF EXUDATE MANAGEMENT ADVANCED WOUND CARE MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 18.HYDROCOLLOID DRESSINGS ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 19.FOAM DRESSINGS ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 20.ALGINATE DRESSINGS ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 21.HYDROGEL DRESSINGS ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR ACTIVE WOUND CARE, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 23.SKIN SUBSTITUTES ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 24.GROWTH FACTORS ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 25.COMPARATIVE ANALYSIS OF THERAPY DEVICES ADVANCED WOUND CARE MARKET, BY COUNTRY,  2019 & 2027 ($MILLION)
FIGURE 26.NEGATIVE PRESSURE WOUND THERAPY MARKET, 2019–2027 ($MILLION)
FIGURE 27.OXYGEN AND HYPERBARIC OXYGEN EQUIPMENT ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 28.ELECTROMAGNETIC THERAPY DEVICES ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 29.OTHERS ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 30.COMPARATIVE ANALYSIS OF CHRONIC WOUND CARE MARKET, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 31.ADVANCED WOUND CARE MARKET FOR PRESSURE ULCERS, 2019–2027 ($MILLION)
FIGURE 32.ADVANCED WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, 2019–2027 ($MILLION)
FIGURE 33.ADVANCED WOUND CARE MARKET FOR VENOUS LEG ULCERS, 2019–2027 ($MILLION)
FIGURE 34.ADVANCED WOUND CARE MARKET FOR ARTERIAL ULCERS, 2019–2027 ($MILLION)
FIGURE 35.COMPARATIVE ANALYSIS OF ACUTE WOUND CARE MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 36.BURNS & TRAUMA WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 37.SURGICAL WOUNDS ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 38.COMPARATIVE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR HOSPITALS, BY COUNTRY,  2019 & 2027 ($MILLION)
FIGURE 39.COMPARATIVE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR COMMUNITY HEALTH SERVICE CENTERS, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 40.3M: NET SALES, 2017–2019 ($MILLION)
FIGURE 41.3M: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 42.3M: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 43.B.BRAUN: NET SALES, 2017–2019 ($MILLION)
FIGURE 44.B.BRAUN: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 45.B.BRAUN: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 46.COLOPLAST: NET SALES, 2017–2019 ($MILLION)
FIGURE 47.COLOPLAST: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 48.COLOPLAST: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 49.CONVATEC: NET SALES, 2017–2019 ($MILLION)
FIGURE 50.CONVATEC: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 51.CONVATEC: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 52.ESSITY: NET SALES, 2017–2019 ($MILLION)
FIGURE 53.ESSITY: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 54.ESSITY: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 55.INTEGRA LIFESCIENCES: NET SALES, 2017–2019 ($MILLION)
FIGURE 56.INTEGRA LIFESCIENCES: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 57.INTEGRA LIFESCIENCES: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 58.INVESTOR: NET SALES, 2017–2019 ($MILLION)
FIGURE 59.INVESTOR: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 60.INVESTOR: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 61.J&J: NET SALES, 2017–2019 ($MILLION)
FIGURE 62.J&J: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 63.J&J: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 64.MEDTRONIC: NET SALES, 2017–2019 ($MILLION)
FIGURE 65.MEDTRONIC REVENUE SHARE, BY SEGMENTS, 2019 (%)
FIGURE 66.MEDTRONIC PLC: REVENUE SHARE, BY REGIONS, 2019 (%)
FIGURE 67.ORGANOGENESIS: NET SALES, 2017–2019 ($MILLION)
FIGURE 68.ORGANOGENESIS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 69.SMITH & NEPHEW: NET SALES, 2017–2019 ($MILLION)
FIGURE 70.SMITH & NEPHEW: REVENUE SHARE, BY SEGMENTS, 2019(%)
FIGURE 71.SMITH & NEPHEW: REVENUE SHARE, BY REGION, 2019 (%)

ADVANCED WOUND CARE MARKET - 2027

The advanced wound care market size was valued at $9,255.70 million in 2019, and is estimated to reach at $15,305.94 million by 2027, registering a CAGR of 11.6% from 2020 to 2027.

Advanced wound care (AWC) products are designed to treat acute & chronic wounds. Chronic wounds take more time to heal and are expensive to treat. Advanced wound care is developing as a standard solution for treating chronic wounds. Traditional wound care products are being increasingly replaced with advanced wound care products, owing to their efficiency & effectiveness in managing wounds by enabling faster healing. Moreover, they help to maintain a hydrated environment, keep temperature consistent, allow flow of oxygen, protect the injured site from exogenous infection, and ease pain associated with dressing changes. Advanced wound care products include hydrocolloids, hydrogels, film & foam dressings, alginates, and others.

Advanced Wound Care - Global Market Study and Forecast Report 2025

Significant increase in the prevalence of chronic diseases such as diabetes and obesity, rise in geriatric population, technological advancements, problems associated with traditional wound healing methods, and surge in adoption of evidence-based treatments for chronic wounds fuel the growth of the advanced wound care market. Moreover, rise in awareness programs for advanced wound care treatment & management attempts to reduce the duration of the hospital stay to lower healthcare expenses, and rise in inclination toward wound care products that enhance therapeutic outcomes are other factors that contribute toward the growth of the market. However, the high costs of advanced wound care products are expected to hinder the growth of the market.

 

ADVANCED WOUND CARE MARKET SEGMENTATION

The advanced wound care market is segmented on the basis of product, application, end-user, and region. By product, the market is segmented into infection management, exudate management, active wound care, and therapy devices. Infection management is further sub-segmented into silver dressings, non-silver dressings, and collagens. The exudate management is further sub-segmented into hydrocolloid dressings, foam dressings, alginate dressings, and hydrogel dressings. The active wound care is further sub-segmented into skin substitutes and growth factors. The therapy devices are further sub-segmented into negative pressure wound therapy (NPWT), oxygen and hyperbaric oxygen equipment, electromagnetic therapy devices, and others. Based on the application, the market is bifurcated into chronic wounds and acute wounds. The chronic wounds is further sub-segmented into pressure ulcers, diabetic foot ulcers, venous leg ulcers, and arterial ulcers. The acute wounds is further sub-segmented into burns & trauma, and surgical wounds. Based on end-user, the advanced wound care market is classified into hospitals and community health service centers. On the basis of region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Advanced Wound Care Market - Global Market Research Report and Future Forecast 2025

Product segment review

Based on advanced wound care market analysis, by product, the market is segmented into infection management, exudate management, active wound care, and therapy devices. The therapy devices segment acquired the largest advanced wound care market share in 2018. Furthermore, this segment is also expected to experience a growth at the fastest rate during the forecast period owing to an increase in the incidence rate of chronic diseases such as diabetes & obesity and a rise in demand for innovative & advanced wound care products

Application Segment review

According to the application, the chronic wound segment generated the highest revenue in 2018 and is expected to maintain its dominance throughout the forecast period. This is attributed to surge in prevalence of post-operative surgical wounds, rise in geriatric population, increase in awareness and improved diagnosis, and technological advancements, which has driven the demand for use of advanced wound care products worldwide.

North America occupied the largest share of the advanced wound care market in 2018 and is expected to maintain its dominance during the forecast period owing to large availability of trained medical professionals, availability of well-developed infrastructure facilities, and presence of majority of key players. However, Asia-Pacific is expected to witness the highest growth rate throughout the forecast period, due to its high population base, surge in disposable income, and rise in patient awareness toward advanced wound care treatment & management. In addition, increase in the geriatric population is the key contributor for the market growth in the region.

The major companies profiled in this report include 3M (Acelity Inc.), Adynxx, Inc., B Braun Melsungen AG, Coloplast A/S, ConvaTec Group plc, Essity AB (BSN Medical GmbH), Integra Lifesciences (Derma sciences), Investor AB (Mölnlycke Health Care AB), Johnson & Johnson, Medline Industries, Inc., Medtronic plc., Organogenesis Holdings Inc., and Smith & Nephew Plc.

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate imminent investment pockets.
  • It offers a quantitative analysis from 2019 to 2027, which is expected to enable stakeholders to capitalize on prevailing advanced wound care market opportunities.
  • The key market players and their strategies have been analyzed to understand the competitive outlook of the advanced wound care market.

By Product type

  • Infection Management 
    • Silver Wound Dressings
    • Non-silver Dressings
    • Collagen Dressings
  • Exudate Management 
    • Hydrocolloids Dressings
    • Foam Dressings
    • Alginate Dressings
    • Hydrogel Dressings
  • Active Wound Care 
    • Skin Substitutes
    • Growth Factors
  • Therapy Devices 
    • Negative Pressure Wound Therapy (NPWT)
    • Oxygen and Hyperbaric Oxygen Equipment
    • Electromagnetic Therapy Devices
    • Others

By Application

  • Chronic Wounds
    • Pressure Ulcers
    • Diabetic Foot Ulcers
    • Venous Leg Ulcers
    • Arterial Ulcers
  • Acute Wounds
    • Burns & Trauma
    • Surgical Wounds

By End User

  • Hospitals
  • Community Health Service Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 
 
 

 

Read More

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five force analysis
3.4.Market share analysis

3.4.1.Drivers

3.4.1.1.Rise in geriatric population
3.4.1.2.Upsurge in incidences of diabetes, obesity, and chronic conditions
3.4.1.3.Technological advancements to deal with complex wounds

3.4.2.Restrains

3.4.2.1.High cost of advanced wound care products

3.4.3.Opportunities

3.4.3.1.Untapped opportunities in developing economies

3.5.Market dynamics
3.6.COVID-19 impact on the market

CHAPTER 4:ADVANCED WOUND CARE MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Infection management

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Market size and forecast, by type
4.2.5.Silver wound dressings

4.2.5.1.Market size and forecast

4.2.6.Non-silver dressings

4.2.6.1.Market size and forecast

4.2.7.Collagen dressings

4.2.7.1.Market size and forecast

4.3.Exudate management

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.3.4.Market size and forecast, by product
4.3.5.Hydrocolloid dressings

4.3.5.1.Market size and forecast

4.3.6.Foam dressings

4.3.6.1.Market size and forecast

4.3.7.Alginate dressings

4.3.7.1.Market size and forecast

4.3.8.Hydrogel dressings

4.3.8.1.Market size and forecast

4.4.Active wound care

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
4.4.4.Market size and forecast, by type
4.4.5.Skin substitutes

4.4.5.1.Market size and forecast

4.4.6.Growth factors

4.4.6.1.Market size and forecast

4.5.Therapy devices

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast
4.5.3.Market analysis, by country
4.5.4.Market size and forecast, by type
4.5.5.Negative pressure wound therapy (NPWT)

4.5.5.1.Market size and forecast

4.5.6.Oxygen & hyperbaric oxygen equipment

4.5.6.1.Market size and forecast

4.5.7.Electromagnetic therapy devices

4.5.7.1.Market size and forecast

4.5.8.Others

4.5.8.1.Market size and forecast

CHAPTER 5:ADVANCED WOUND CARE MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Chronic wounds

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.2.3.Market size and forecast, by type
5.2.4.Pressure ulcers

5.2.4.1.Market size and forecast

5.2.5.Diabetic foot ulcers

5.2.5.1.Market size and forecast

5.2.6.Venous leg ulcers

5.2.6.1.Market size and forecast

5.2.7.Arterial ulcers

5.2.7.1.Market size and forecast

5.3.Acute wounds

5.3.1.Market size and forecast
5.3.2.Market analysis, by country
5.3.3.Market size and forecast, by type
5.3.4.Burns & trauma

5.3.4.1.Market size and forecast

5.3.5.Surgical wounds

5.3.5.1.Market size and forecast

CHAPTER 6:ADVANCED WOUND CARE MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Hospitals

6.2.1.Market size and forecast
6.2.2.Market analysis, by country

6.3.Community health service centers

6.3.1.Market size and forecast
6.3.2.Market analysis, by country

CHAPTER 7:ADVANCED WOUND CARE MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country

7.2.2.1.U.S. advanced wound care market, by product
7.2.2.2.U.S. advanced wound care market, by application
7.2.2.3.U.S. advanced wound care market, by end user
7.2.2.4.Mexico advanced wound care market, by product
7.2.2.5.Mexico advanced wound care market, by application
7.2.2.6.Mexico advanced wound care market, by end user
7.2.2.7.Canada advanced wound care market, by product
7.2.2.8.Canada advanced wound care market, by application
7.2.2.9.Canada advanced wound care market, by end user

7.2.3.North America market size and forecast, by product
7.2.4.North America market size and forecast, by application
7.2.5.North America market size and forecast, by end user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country

7.3.2.1.Germany advanced wound care market, by product
7.3.2.2.Germany advanced wound care market, by application
7.3.2.3.Germany advanced wound care market, by end user
7.3.2.4.UK advanced wound care market, by product
7.3.2.5.UK advanced wound care market, by application
7.3.2.6.UK advanced wound care market, by end user
7.3.2.7.France advanced wound care market, by product
7.3.2.8.France advanced wound care market, by application
7.3.2.9.France advanced wound care market, by end user
7.3.2.10.Italy advanced wound care market, by product
7.3.2.11.Italy advanced wound care market, by application
7.3.2.12.Italy advanced wound care market, by end user
7.3.2.13.Spain advanced wound care market, by product
7.3.2.14.Spain advanced wound care market, by application
7.3.2.15.Spain advanced wound care market, by end user
7.3.2.16.Rest of Europe advanced wound care market, by product
7.3.2.17.Rest of Europe advanced wound care market, by application
7.3.2.18.Rest of Europe advanced wound care market, by end user

7.3.3.Europe market size and forecast, by product
7.3.4.Europe market size and forecast, by application
7.3.5.Europe market size and forecast, by end user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country

7.4.2.1.Japan advanced wound care market, by product
7.4.2.2.Japan advanced wound care market, by application
7.4.2.3.Japan advanced wound care market, by end user
7.4.2.4.China advanced wound care market, by product
7.4.2.5.China advanced wound care market, by application
7.4.2.6.China advanced wound care market, by end user
7.4.2.7.India advanced wound care market, by product
7.4.2.8.India advanced wound care market, by application
7.4.2.9.India advanced wound care market, by end user
7.4.2.10.Rest of Asia-Pacific advanced wound care market, by product
7.4.2.11.Rest of Asia-Pacific advanced wound care market, by application
7.4.2.12.Rest of Asia-Pacific advanced wound care market, by end user

7.4.3.Asia-Pacific market size and forecast, by product
7.4.4.Asia-Pacific market size and forecast, by application
7.4.5.Asia-Pacific market size and forecast, by end user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country

7.5.2.1.Brazil advanced wound care market, by product
7.5.2.2.Brazil advanced wound care market, by application
7.5.2.3.Brazil advanced wound care market, by end user
7.5.2.4.Saudi Arabia advanced wound care market, by product
7.5.2.5.Saudi Arabia advanced wound care market, by application
7.5.2.6.Saudi Arabia advanced wound care market, by end user
7.5.2.7.South Africa advanced wound care market, by product
7.5.2.8.South Africa advanced wound care market, by application
7.5.2.9.South Africa advanced wound care market, by end user
7.5.2.10.Rest of LAMEA advanced wound care market, by product
7.5.2.11.Rest of LAMEA advanced wound care market, by application
7.5.2.12.Rest of LAMEA advanced wound care market, by end user

7.5.3.LAMEA market size and forecast, by product
7.5.4.LAMEA market size and forecast, by application
7.5.5.LAMEA market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

8.1.3M (ACELITY INC.)

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments

8.2.ADYNXX, INC.

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Key strategic moves and developments

8.3.B. BRAUN MELSUNGEN AG

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance

8.4.COLOPLAST A/S

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance

8.5.CONVATEC GROUP PLC.

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance

8.6.ESSITY AB (BSN MEDICAL GMBH)

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments

8.7.INTEGRA LIFESCIENCES HOLDINGS CORPORATION (DERMA SCIENCES)

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments

8.8.INVESTOR AB (MÖLNLYCKE HEALTH CARE AB)

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments

8.9.JOHNSON & JOHNSON

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance

8.10.MEDLINE INDUSTRIES, INC.

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio

8.11.MEDTRONIC PLC.

8.11.1.Company overview
8.11.2.Company snapshot
8.11.3.Operating business segments
8.11.4.Product portfolio
8.11.5.Business performance

8.12.ORGANOGENESIS HOLDINGS INC.

8.12.1.Company overview
8.12.2.Company snapshot
8.12.3.Operating business segments
8.12.4.Product portfolio
8.12.5.Business performance

8.13.SMITH & NEPHEW PLC.

8.13.1.Company overview
8.13.2.Company snapshot
8.13.3.Operating business segments
8.13.4.Product portfolio
8.13.5.Business performance

Read More

TABLE 01.GLOBAL INCIDENCES OF DIABETES, 2011 VS. 2030 (IN MILLION)
TABLE 02.GLOBAL ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 03.INFECTION MANAGEMENT ADVANCED WOUND CARE MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 04.INFECTION MANAGEMENT ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 05.EXUDATE MANAGEMENT ADVANCED WOUND CARE MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 06.EXUDATE MANAGEMENT ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 07.ADVANCED WOUND CARE MARKET FOR ACTIVE WOUND CARE, BY REGION, 2019–2027 ($MILLION)
TABLE 08.ACTIVE WOUND CARE MARKET ADVANCED WOUND CARE, BY TYPE, 2019–2027 ($MILLION)
TABLE 09.THERAPY DEVICES ADVANCED WOUND CARE MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 10.THERAPY DEVICES ADVANCED WOUND CARE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 11.GLOBAL ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 12.CHRONIC WOUND CARE MARKET, BY REGION, 2018–2027 ($MILLION)
TABLE 13.CHRONIC WOUND CARE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 14.PRESSURE ULCER-RELATED PRODUCTS AND MANUFACTURERS
TABLE 15.CLINICAL TRIALS 1 – PRESSURE ULCERS
TABLE 16.CLINICAL TRIALS 2 - PRESSURE ULCERS
TABLE 17.CLINICAL TRIALS 1 - DIABETIC FOOT ULCERS
TABLE 18.CLINICAL TRIALS 2 - DIABETIC FOOT ULCERS
TABLE 19.CLINICAL TRIALS 1 – VENOUS LEG ULCERS
TABLE 20.CLINICAL TRIALS 2 - VENOUS LEG ULCERS
TABLE 21.CLINICAL TRIALS – ARTERIAL ULCERS
TABLE 22.ACUTE WOUND CARE MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 23.ACUTE WOUND CARE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 24.GLOBAL ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 25.ADVANCED WOUND CARE MARKET FOR HOSPITALS, BY REGION, 2019–2027 ($MILLION)
TABLE 26.ADVANCED WOUND CARE MARKET FOR COMMUNITY HEALTH SERVICE CENTERS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 27.ADVANCED WOUND CARE MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 28.NORTH AMERICA ADVANCED WOUND CARE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 29.U.S. ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 30.U.S. ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 31.U.S. ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 32.MEXICO ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 33.MEXICO ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 34.MEXICO ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 35.CANADA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 36.CANADA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 37.CANADA ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 38.NORTH AMERICA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 39.NORTH AMERICA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 40.NORTH AMERICA ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 41.EUROPE ADVANCED WOUND CARE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 42.GERMANY ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 43.GERMANY ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 44.GERMANY ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 45.UK ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 46.UK ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 47.UK ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 48.FRANCE ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 49.FRANCE ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 50.FRANCE ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 51.ITALY ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 52.ITALY ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 53.ITALY ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 54.SPAIN ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 55.SPAIN ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 56.SPAIN ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 57.REST OF EUROPE ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 58.REST OF EUROPE ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 59.REST OF EUROPE ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 60.EUROPE ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 61.EUROPE ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 62.EUROPE ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 63.ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 64.JAPAN ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 65.JAPAN ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 66.JAPAN ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 67.CHINA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 68.CHINA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 69.CHINA ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 70.INDIA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 71.INDIA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 72.INDIA ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 73.REST OF ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 74.REST OF ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 75.REST OF ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 76.ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 77.ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 78.ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 79.LAMEA ADVANCED WOUND CARE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 80.BRAZIL ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 81.BRAZIL ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 82.BRAZIL ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 83.SAUDI ARABIA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 84.SAUDI ARABIA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 85.SAUDI ARABIA ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 86.SOUTH AFRICA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 87.SOUTH AFRICA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 88.SOUTH AFRICA ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 89.REST OF LAMEA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 90.REST OF LAMEA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 91.REST OF LAMEA ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 92.LAMEA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027
TABLE 93.LAMEA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027
TABLE 94.LAMEA ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027
TABLE 95.3M: COMPANY SNAPSHOT
TABLE 96.3M: OPERATING SEGMENTS
TABLE 97.3M: PRODUCT PORTFOLIO
TABLE 98.ADYNXX: COMPANY SNAPSHOT
TABLE 99.ADYNXX: PRODUCT PORTFOLIO
TABLE 100.B. BRAUN: COMPANY SNAPSHOT
TABLE 101.B. BRAUN :OPERATING SEGMENTS
TABLE 102.B BRAUN: PRODUCT PORTFOLIO
TABLE 103.COLOPLAST: COMPANY SNAPSHOT
TABLE 104.COLOPLAST: OPERATING SEGMENTS
TABLE 105.COLOPLAST: PRODUCT PORTFOLIO
TABLE 106.CONVATEC: COMPANY SNAPSHOT
TABLE 107.CONVATEC: OPERATING SEGMENTS
TABLE 108.CONVATEC: PRODUCT PORTFOLIO
TABLE 109.ESSITY: COMPANY SNAPSHOT
TABLE 110.ESSITY: OPERATING SEGMENTS
TABLE 111.ESSITY: PRODUCT PORTFOLIO
TABLE 112.INTEGRA LIFESCIENCES: COMPANY SNAPSHOT
TABLE 113.INTEGRA LIFESCIENCES: OPERATING SEGMENTS
TABLE 114.INTEGRA LIFESCIENCES: PRODUCT PORTFOLIO
TABLE 115.INVESTOR: COMPANY SNAPSHOT
TABLE 116.INVESTOR: OPERATING SEGMENTS
TABLE 117.INVESTOR: PRODUCT PORTFOLIO
TABLE 118.J&J: COMPANY SNAPSHOT
TABLE 119.J&J: OPERATING SEGMENTS
TABLE 120.J&J: PRODUCT PORTFOLIO
TABLE 121.MEDLINE: COMPANY SNAPSHOT
TABLE 122.MEDLINE: OPERATING SEGMENTS
TABLE 123.MEDLINE: PRODUCT PORTFOLIO
TABLE 124.MEDTRONIC: COMPANY SNAPSHOT
TABLE 125.MEDTRONIC: OPERATING SEGMENTS
TABLE 126.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 127.ORGANOGENESIS: COMPANY SNAPSHOT
TABLE 128.ORGANOGENESIS: OPERATING SEGMENTS
TABLE 129.ORGANOGENESIS: PRODUCT PORTFOLIO
TABLE 130.SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 131.SMITH & NEPHEW: OPERATING SEGMENTS
TABLE 132.SMITH & NEPHEW: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.GLOBAL ADVANCED WOUND CARE MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017–2020
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2020 (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2017–2020
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTES
FIGURE 09.LOW THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.MARKET SHARE ANALYSIS
FIGURE 12.MARKET DYNAMICS
FIGURE 13.COMPARATIVE ANALYSIS OF INFECTION MANAGEMENT ADVANCED WOUND CARE MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 14.SILVER WOUND DRESSINGS ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 15.NON-SILVER DRESSINGS ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 16.COLLAGEN DRESSINGS ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF EXUDATE MANAGEMENT ADVANCED WOUND CARE MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 18.HYDROCOLLOID DRESSINGS ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 19.FOAM DRESSINGS ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 20.ALGINATE DRESSINGS ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 21.HYDROGEL DRESSINGS ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR ACTIVE WOUND CARE, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 23.SKIN SUBSTITUTES ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 24.GROWTH FACTORS ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 25.COMPARATIVE ANALYSIS OF THERAPY DEVICES ADVANCED WOUND CARE MARKET, BY COUNTRY,  2019 & 2027 ($MILLION)
FIGURE 26.NEGATIVE PRESSURE WOUND THERAPY MARKET, 2019–2027 ($MILLION)
FIGURE 27.OXYGEN AND HYPERBARIC OXYGEN EQUIPMENT ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 28.ELECTROMAGNETIC THERAPY DEVICES ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 29.OTHERS ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 30.COMPARATIVE ANALYSIS OF CHRONIC WOUND CARE MARKET, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 31.ADVANCED WOUND CARE MARKET FOR PRESSURE ULCERS, 2019–2027 ($MILLION)
FIGURE 32.ADVANCED WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, 2019–2027 ($MILLION)
FIGURE 33.ADVANCED WOUND CARE MARKET FOR VENOUS LEG ULCERS, 2019–2027 ($MILLION)
FIGURE 34.ADVANCED WOUND CARE MARKET FOR ARTERIAL ULCERS, 2019–2027 ($MILLION)
FIGURE 35.COMPARATIVE ANALYSIS OF ACUTE WOUND CARE MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 36.BURNS & TRAUMA WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 37.SURGICAL WOUNDS ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 38.COMPARATIVE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR HOSPITALS, BY COUNTRY,  2019 & 2027 ($MILLION)
FIGURE 39.COMPARATIVE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR COMMUNITY HEALTH SERVICE CENTERS, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 40.3M: NET SALES, 2017–2019 ($MILLION)
FIGURE 41.3M: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 42.3M: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 43.B.BRAUN: NET SALES, 2017–2019 ($MILLION)
FIGURE 44.B.BRAUN: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 45.B.BRAUN: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 46.COLOPLAST: NET SALES, 2017–2019 ($MILLION)
FIGURE 47.COLOPLAST: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 48.COLOPLAST: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 49.CONVATEC: NET SALES, 2017–2019 ($MILLION)
FIGURE 50.CONVATEC: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 51.CONVATEC: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 52.ESSITY: NET SALES, 2017–2019 ($MILLION)
FIGURE 53.ESSITY: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 54.ESSITY: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 55.INTEGRA LIFESCIENCES: NET SALES, 2017–2019 ($MILLION)
FIGURE 56.INTEGRA LIFESCIENCES: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 57.INTEGRA LIFESCIENCES: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 58.INVESTOR: NET SALES, 2017–2019 ($MILLION)
FIGURE 59.INVESTOR: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 60.INVESTOR: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 61.J&J: NET SALES, 2017–2019 ($MILLION)
FIGURE 62.J&J: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 63.J&J: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 64.MEDTRONIC: NET SALES, 2017–2019 ($MILLION)
FIGURE 65.MEDTRONIC REVENUE SHARE, BY SEGMENTS, 2019 (%)
FIGURE 66.MEDTRONIC PLC: REVENUE SHARE, BY REGIONS, 2019 (%)
FIGURE 67.ORGANOGENESIS: NET SALES, 2017–2019 ($MILLION)
FIGURE 68.ORGANOGENESIS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 69.SMITH & NEPHEW: NET SALES, 2017–2019 ($MILLION)
FIGURE 70.SMITH & NEPHEW: REVENUE SHARE, BY SEGMENTS, 2019(%)
FIGURE 71.SMITH & NEPHEW: REVENUE SHARE, BY REGION, 2019 (%)

Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$5769
This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)
$6450
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)
$8995
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Seventh Sense AI

RELATED REPORTS

Global Negative Pressure Wound Therapy Market Research Report 2021
Global Negative Pressure Wound Therapy Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-6C4528
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Paclitaxel Injection Market Research Report 2021
Global Paclitaxel Injection Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-5J4435
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Myotonic Dystrophy Medication Market Size Status and Forecast 2021 2027
Global Myotonic Dystrophy Medication Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-10R4400
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Transthyretin amyloid cardiomyopathy ATTR CM Treatment Market Size Status and Forecast 2021 2027
Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-0N4529
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0